Actavis Buys Auden Mckenzie, Now UK’s Largest Generics Firm

Actavis (ACT) announced today that it will purchase generic-drug maker Auden Mckenzie Holdings for £306 million (nearly $460 million), a deal that will make it the U.K.’s largest supplier of generics. Auden, along with Allergan, which Actavis wrested from Valeant Pharmaceuticals (VRX) in a $66 billion acquisition, will also make Actavis the nation’s largest pharmaceutical [...]